Pilot corpus: NIH-funded biomedical datasets. Any DOI can be scored on demand — network effects sharpen as coverage grows.

SARS‐CoV‐2 show no infectivity at later stages in a prolonged COVID‐19 patient despite positivity in RNA testing

Journal of Medical Virology(2021)10.1002/jmv.27001Source: DataRank Database

SARS‐CoV‐2 show no infectivity at later stages in a prolonged COVID‐19 patient despite positivity in RNA testing is a research paper published in Journal of Medical Virology (2021). On theSindex it has a DataRank of 0. It has been cited 6 times.

N/A

0DataRank · unranked

Scored on demand from live citation data

Open Access6 citations

Download PDF

Cite:

Linked data & code

gen refseq

DataRank reads this dataset's downstream impact straight off the citation graph — no black box, no proprietary weighting. How is this computed?

›Methodology & internals

datarank_citation_only_1hop_v6· scope data_onlyMethodology

Pipeline:MetadataData-paper checkEnrichmentCitation networkScoring

Enrichment:Funding (4 grants)Impact (FWCI 0.37)OA: bronzeTopics (62)IDs (PubMed, PMC, OpenAlex)Annotations (2)SDGs (2)

FAIR Checklist

Context only (not used in score)

Findable (1/2)

Has DOI

Accessible (1/2)

Open Access

Interoperable (0/2)

Reusable (0/3)

FAIR checklist signals are shown for context only and do not affect DataRank scoring.

Run a calibrated FAIR evaluation for this paper →

We only score data papers we can read in full — never from an abstract alone.

Authors (16)

Cynthia Y. Tang ORCID,Detlef Ritter ORCID,Yang Wang ORCID,Tao Li ORCID,Karen Segovia ORCID

Live enrichment

PubMed:33830520 PMC:PMC8250787 OpenAlex:https://openalex.org/W3146874674

National Science Foundation

Grant: 5T32LM012410

NLM NIH HHS

Grant: T32 LM012410

Global Emerging Infections Surveillance Branch of the Armed Forces Health Surveillance Division

Grant: ProMIS ID P0140_20_WR_01.Global

National Institutes of Health

Grant: 5T32LM012410-05

Massive and Complex Data Analytics Pre-Doctoral Training in One Health

FWCI

0.37

Citation Percentile

0.6%

Citation Trend

2021

2022

bronzeLicense: Wiley Online Library User Agreement

journalhttps://onlinelibrary.wiley.com/doi/pdfdirect/10.1002/jmv.27001

publisherhttps://onlinelibrary.wiley.com/doi/pdfdirect/10.1002/jmv.27001

publisherhttps://onlinelibrary.wiley.com/doi/pdf/10.1002/jmv.27001

publisherhttps://onlinelibrary.wiley.com/doi/full-xml/10.1002/jmv.27001

journalhttps://doi.org/10.1002/jmv.27001

Fields of Study

SARS-CoV-2 detection and testingSARS-CoV-2 and COVID-19 ResearchCOVID-19 Clinical Research Studies0303 health sciences03 medical and health sciencesAgedAntibodies, NeutralizingAntibodies, ViralAsymptomatic InfectionsCOVID-19COVID-19 Nucleic Acid TestingHumansMaleRNA, ViralReverse Transcriptase Polymerase Chain ReactionSARS-CoV-2Virus Shedding

MeSH Terms

COVID-19SARS-CoV-2COVID-19 Nucleic Acid TestingAgedAntibodies, ViralHumansMaleRNA, ViralVirus SheddingReverse Transcriptase Polymerase Chain ReactionAntibodies, NeutralizingAsymptomatic Infections

Keywords

InfectivityMedicineAsymptomaticCoronavirus disease 2019 (COVID-19)Transmission (telecommunications)SerologySevere acute respiratory syndrome coronavirus 2 (SARS-CoV-2)VirologyInfection controlDiseaseVirusDiscontinuationInternal medicineEmergency medicineInfectious disease (medical specialty)Intensive care medicineImmunologyAntibodyreal-time polymerase chain reactioninpatientsPatient DischargeCovid-19Sars-cov-2MaleReverse Transcriptase Polymerase Chain ReactionAntibodies, ViralAntibodies, NeutralizingVirus SheddingCOVID-19 Nucleic Acid TestingHumansRNA, ViralAsymptomatic InfectionsAged

Sustainable Development Goals

SDG 3: 3. Good healthSDG 0: Good health and well-being